Literature DB >> 23937069

Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells.

Jung-hua Steven Kuo1, Chia-Wei Lin.   

Abstract

Rath peptide has been introduced as a delivery vector that transports various membrane-impermeable cargoes in a non-covalent fashion. In this paper, we present a study on Rath peptide conjugated with fluorescein-5-isothiocynate (FITC) differing in its N- and C-termini. We conducted cellular toxicity and uptake experiments in U-937 and HeLa cells to analyze biocompatibility profiles and translocation efficiencies of Rath peptide with FITC serving as both a cargo and a fluorescent marker. We found that the conjugation of FITC on Rath peptide at N-terminus (FITC-Rath) led to more rapid cellular uptake in U-937 cells and significantly higher cellular uptake in HeLa cells than that which occurred at C-terminus. From DNA microarray analysis, FITC-Rath induced gene expression changes in both U-937 and HeLa cells. Five overlapping regulated genes were identified, and this overlap indicated that FITC-Rath displayed some degree of generality regarding gene responses in the two cell lines used. A real-time quantitative reverse transcriptase-polymerase chain reaction was used to confirm which regulated genes were affected by FITC-Rath. Cell communication, signal transduction, cell surface receptor signaling pathway, signal transducer activity and cellular process, were identified as overlapping biological themes. These data provide useful information on molecular mechanisms for using Rath-based delivery systems.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23937069     DOI: 10.3109/1061186X.2013.824456

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  1 in total

1.  Novel Somatic Copy Number Alteration Identified for Cervical Cancer in the Mexican American Population.

Authors:  Alireza Torabi; Javier Ordonez; Brenda Bin Su; Laura Palmer; Chunxiang Mao; Katherine E Lara; Lewis P Rubin; Chun Xu
Journal:  Med Sci (Basel)       Date:  2016-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.